Innoviva (INVA) EBT (2010 - 2026)
Innoviva (INVA) reported EBT of $234.6 million for Q1 2026, up 707.85% on a YoY basis from $29.0 million in Q1 2025, and up 1796.9% quarter-over-quarter from -$13.8 million in Q4 2025.
Innoviva (INVA) EBT (2010 - 2026) Analysis & Trends
Innoviva has reported EBT for 17 years, with the latest figure at $234.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 707.85% year-over-year to $234.6 million; the trailing twelve-month figure through Mar 2026 stood at $391.2 million (up 579.6% YoY), and the FY2025 full-year result was $327.1 million, up 775.38% from the prior year.
- EBT for Q1 2026 stood at $234.6 million, up from -$13.8 million in the prior quarter.
- The five-year high for EBT was $286.4 million in Q3 2022, with the low at -$39.3 million in Q2 2024.
- Historically, EBT has averaged $48.4 million across 5 years, with a median of $20.5 million in 2022.
- Annual changes were most pronounced in 2024 — EBT sank 776.64% — and 2025, when it soared 1328.19%.
- Innoviva's EBT stood at -$10.3 million in 2022, then jumped by 36.31% to -$6.6 million in 2023, then sank by 60.22% to -$10.5 million in 2024, then plunged by 31.16% to -$13.8 million in 2025, then jumped by 1796.9% to $234.6 million in 2026.
- The last three EBT figures came in at $234.6 million (Q1 2026), -$13.8 million (Q4 2025), and $97.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.48 Mn |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 234.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.56 Mn |
| Dec 31, 2025 | -13.82 Mn |
| Sep 30, 2025 | 97.82 Mn |
| Jun 30, 2025 | 72.60 Mn |
| Mar 31, 2025 | -38.59 Mn |
| Dec 31, 2024 | -10.54 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | -39.28 Mn |
| Mar 31, 2024 | 45.12 Mn |
| Dec 31, 2023 | -6.58 Mn |
| Sep 30, 2023 | 85.95 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 41.14 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 286.42 Mn |
| Jun 30, 2022 | 20.50 Mn |
| Mar 31, 2022 | 44.72 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | 123.18 Mn |
| Jun 30, 2021 | 136.18 Mn |